Stock Traders Buy Large Volume of Call Options on Masimo (NASDAQ:MASI)

Posted by Defense World Staff on Sep 26th, 2023

Masimo Co. (NASDAQ:MASI – Get Free Report) was the recipient of some unusual options trading activity on Monday. Investors purchased 11,875 call options on the company. This is an increase of approximately 1,680% compared to the average volume of 667 call options.

Masimo Stock Performance

Shares of Masimo stock opened at $91.37 on Tuesday. The company has a market capitalization of $4.83 billion, a PE ratio of 42.70 and a beta of 0.81. The company has a 50-day simple moving average of $111.08 and a two-hundred day simple moving average of $150.45. Masimo has a one year low of $90.87 and a one year high of $198.00. The company has a debt-to-equity ratio of 0.68, a quick ratio of 1.16 and a current ratio of 2.11.

Masimo (NASDAQ:MASI – Get Free Report) last announced its quarterly earnings data on Tuesday, August 8th. The medical equipment provider reported $0.62 EPS for the quarter, missing the consensus estimate of $0.86 by ($0.24). The company had revenue of $455.30 million during the quarter, compared to analysts’ expectations of $478.27 million. Masimo had a net margin of 5.30% and a return on equity of 15.79%. The business’s revenue for the quarter was down 19.5% compared to the same quarter last year. During the same period in the previous year, the business earned $1.35 earnings per share. Research analysts expect that Masimo will post 3.45 EPS for the current fiscal year.

Hedge Funds Weigh In On Masimo

Several hedge funds and other institutional investors have recently bought and sold shares of the business. National Bank of Canada FI acquired a new stake in shares of Masimo during the 2nd quarter worth approximately $29,000. Caisse DE Depot ET Placement DU Quebec purchased a new position in shares of Masimo during the 1st quarter worth $37,000. Achmea Investment Management B.V. purchased a new position in shares of Masimo during the 2nd quarter worth $39,000. Trivant Custom Portfolio Group LLC purchased a new position in shares of Masimo during the 1st quarter worth $55,000. Finally, Massmutual Trust Co. FSB ADV increased its position in shares of Masimo by 202.7% during the 2nd quarter. Massmutual Trust Co. FSB ADV now owns 342 shares of the medical equipment provider’s stock worth $56,000 after purchasing an additional 229 shares during the last quarter. Institutional investors and hedge funds own 85.96% of the company’s stock.

Analyst Ratings Changes

Several equities analysts have recently weighed in on the stock. StockNews.com cut shares of Masimo from a “hold” rating to a “sell” rating in a research note on Wednesday, September 13th. Needham & Company LLC reaffirmed a “buy” rating and set a $136.00 price objective on shares of Masimo in a research note on Wednesday, August 9th. Raymond James dropped their price objective on shares of Masimo from $198.00 to $142.00 and set an “outperform” rating for the company in a research note on Thursday, August 10th. Stifel Nicolaus lowered shares of Masimo from a “buy” rating to a “hold” rating and lowered their target price for the company from $205.00 to $120.00 in a research note on Tuesday, July 18th. Finally, Wells Fargo & Company lowered their target price on shares of Masimo from $126.00 to $110.00 and set an “equal weight” rating for the company in a research note on Wednesday, August 9th. One analyst has rated the stock with a sell rating, three have given a hold rating and four have issued a buy rating to the company. According to data from MarketBeat, the company has an average rating of “Hold” and an average price target of $141.57.

Check Out Our Latest Analysis on Masimo

About Masimo

(Get Free Report)

Masimo Corporation develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of carboxyhemoglobin, methemoglobin, hemoglobin concentration, fractional arterial oxygen saturation, oxygen content, pleth variability index, rainbow pleth variability index, respiration rate from the pleth, and oxygen reserve index, as well as acoustic respiration monitoring, SedLine brain function monitoring, NomoLine capnography and gas monitoring, and O3 regional oximetry.